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Abstract
Spherical three-dimensional cell aggregates called embryoid bodies (EBs), have been widely used in in vitro differentiation
protocols for human pluripotent stem cells including human embryonic stem cells (hESCs) and human induced pluripotent
stem cells (hiPSCs). Recent studies highlight the new devices and techniques for hEB formation and expansion, but are not
involved in the passaging or subculture process. Here, we provide evidence that a simple periodic passaging markedly
improved hEB culture condition and thus allowed the size-controlled, mass production of human embryoid bodies (hEBs)
derived from both hESCs and hiPSCs. hEBs maintained in prolonged suspension culture without passaging (.2 weeks)
showed a progressive decrease in the cell growth and proliferation and increase in the apoptosis compared to 7-day-old
hEBs. However, when serially passaged in suspension, hEB cell populations were significantly increased in number while
maintaining the normal rates of cell proliferation and apoptosis and the differentiation potential. Uniform-sized hEBs
produced by manual passaging using a 1:4 split ratio have been successfully maintained for over 20 continuous passages.
The passaging culture method of hEBs, which is simple, readily expandable, and reproducible, could be a powerful tool for
improving a robust and scalable in vitro differentiation system of human pluripotent stem cells.
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Introduction
The unlimited potential of human embryonic stem cells (hESCs)
and human induced pluripotent stem cells (hiPSCs) to differentiate
into all of the cell types present in the body provides great
opportunities for basic research, drug discovery, and regenerative
medicine. However, a major bottleneck to the ultimate use of these
cells is the large-scale production of pluripotent hESCs/hiPSCs
and their differentiated derivatives. Substantial progress has been
achieved with respect to culture conditions that support the long-
term and scalable expansion of hESCs/hiPSCs [1–4], but current
techniques still do not allow efficient, economized large-scale
production.
To derive or obtain tissue-specific differentiated cells from
hESCs/hiPSCs, most in vitro hESC/hiPSC differentiation proto-
cols requires an initial spontaneous formation of embryoid bodies
(EBs), which is a common and critical intermediate for the
induction of lineage-specific differentiation [5–7]. Conventionally,
human embryoid bodies (hEBs) can be formed in suspension
cultures through releasing attached cultured hESC/hiPSC
colonies to culture medium using enzymatic and mechanical
(scraping) methods and further being maintained in suspension
without subculture. An early stage of hEBs maintained for about
10 days in suspension were largely used for further differentiation
into specific lineage. However, such techniques yield a heteroge-
neous cell population both between and within aggregates, which
results in a limited developmental potential and a low production
yield. Report showed that long-term culturing of hEBs could be
achieved under the physiological media glucose condition while
maintaining embryonic developmental potential, but in a chaotic
and disorganized way [8]. Therefore, alternative methods to
facilitate hEB formation and culture systems have been explored,
including stirred suspension cultures [9,10], bioreactor cultures
[11], and the formation of spin EBs that are aggregated by
centrifugation [12,13]. Study also showed that production of hEBs
with a more uniform size could be advanced using the single-cell
suspension method and the 3-D cuboidal microwell system [14].
But still lack of knowledge of specific phenotypic features and a
method of large-scale expansion and long-term propagation of
hEBs limits the usefulness of human pluripotent stem cells.
In this paper, we have established and characterized a
subculture method of hEBs that allows the scalable and the
long-term propagation of hEB without loss of their proliferation
and differentiation potential. This method, when combined with
suspension culture system with bioreactors, will facilitate the large-
scale expansion of hEBs and hEB-based differentiation for cell-
based therapeutics.
Our culture method of hEBs achieved in this study may
substantially contribute to bypass or diminish the requirement for
the large-scale production of hESCs/hiPSCs and to advance and
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19134ensure the quality of hEBs, such as consistent morphological and
developmental characteristics (i.e., size, shape, and multi-lineage
differentiation potential).
Materials and Methods
hESC and hiPSC cultures
The human embryonic stem cell (hESC) lines H9 (NIH Code,
WA09, XX, passages 28–47; WiCell Research Institute, Madison,
WI) and H1 (NIH Code, WA01 XY, passages 33–40; WiCell
Research Institute) and human induced pluripotent cell (hiPSC)
lines [15] were routinely maintained on c-irradiated mouse
embryonic fibroblasts (MEFs) in hESC culture medium consisting
of 80% DMEM/F12 medium, 20% knockout serum replacement
(KSR, Invitrogen), 1% non-essential amino acids (NEAA, Invitro-
gen), 1 mM L-glutamine (Invitrogen), 0.1 mM b-mercaptoethanol
(Sigma, St. Louis, MO) and 6 ng/ml basic fibroblast growth factor
(bFGF, Invitrogen). MEFs were prepared from day 12.5 p.c. fetuses
of CF-1 mice according to standard procedures [16]. The cells were
passagedusingmechanicalorcollagenase-basedenzymaticmethods
every 5–6 days [17]. All cultures were routinely screened for
mycoplasma, and normal karyotype was monitored by chromo-
somal G-band analysis (GenDix, Inc., Seoul, Korea). Our research
wasperformedunderethical approvalfromtheInstitutional Review
Board (IRB) at KRIBB, Korea (KRIBB-IRB-20090916-1).
hEB propagation
For hEB maintenance, three different methods were used, as
depicted in Figure 1a. In the first method (Fig. 1Ai), 7-day-old
hESCs/hiPSCs were harvested with collagenase IV (1 mg/ml) and
dispersed into small clumps by scraping and pipetting. The
resulting clumps were added to the non-tissue culture treated
Figure 1. Long-term-cultured hEBs derived from hESCs and hiPSCs. (A) Schematic representations of the hEB culture conditions with and
without passaging. w: week, p: passage. Step 1: Period of hEB formation, Step 2: Period of hEB maintenance and expansion. (B) Morphologies of the
cultured hEBs with or without passaging for various times as indicated. (i and ii) H9 hESC-derived hEBs cultured without passaging (conventional
method). (iii) H9 hESC-derived hEBs cultured with passaging. For subculturing, hEBs were sliced at a ratio of 1:4 every 7 days. The medium was
changed every 3 days (i–iii). (C) Representative images of regular-sized hEB formation. (Top) Seven-day-old (7 d) hESCs (H1 and H9 hES) and OSKM-
induced hiPSCs (OSKM-hiPS). (Middle top) hESC and iPSC colonies sliced into a grid pattern (6006600 mm) using a McIlwain tissue chopper prior to
dislodgement. Cell nuclei were visualized with DAPI. (Middle bottom) Mechanically dislodged colonies in suspension culture. (Bottom) The 7 d-hEB
population in suspension culture. (D) Representative images of the hEB passaging process. The 7 d-hEBs derived from H9 hESCs (Top) were
mechanically dissociated into smaller aggregates at ratios of 1:2, 1:4, and 1:6 (Middle top). (Middle bottom) Phase contrast images of passaged hEBs
cultured for 1 day. (Bottom) Representative images of passaged hEBs exhibiting complete re-growth to normal size.
doi:10.1371/journal.pone.0019134.g001
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periods in hEB medium consisting of Knockout DMEM
(Invitrogen), 20% FBS (Invitrogen), 1% non-essential amino acids,
1 mM L-glutamine, 0.1 mM b-mercaptoethanol, and 1% penicil-
lin/streptomycin (Fig. 1Ai). Seven-day-old hESCs/hiPSCs were
disaggregated into regular-sized squares (6006600 mm) using a
McIlwain tissue chopper to produce uniform hESC clumps
(Fig. 1Aii and iii). In the second method (Fig. 1Aii), uniform
clumps were seeded onto plastic petri dishes and cultured
continuously in suspension for the indicated periods in hEB
medium without subculture. In the third method proposed herein
(Fig. 1Aiii), uniform clumps that were seeded onto plastic petri
Figure 2. Size and number of hEBs under various culture conditions. The growth curves were determined either by counting the average
number of cells per hEB or by measuring the mean diameter of each hEB. (A) hEB cell counts during the first week of incubation. Step 1 culture shown
in Fig. 1A. (B) Diameters of the hEBs during long-term culture without passaging. Step 1(1 to 7 days) and Step 2 (1 to 5 weeks) cultures shown in
Fig. 1A. (C) Cell counts for the passaged H9 hEBs. (D) Diameters of the passaged H9 hEBs. hEBs were passaged at ratios of 1:2, 1:4, and 1:6 (C and D).
(E) Cell counts for hEBs that were passaged five times. hEBs were passaged at a ratio of 1:4. (F) Diameters of the H9 hEBs during 15 continuous serial
passages. hEBs were passaged at a ratio of 1:4. The results represent the mean values (6 SEM) of samples obtained from a representative experiment
performed in triplicate. w: week, p: passage. Arrows indicate the passaging day (C, D, and F). (G) Cell counts for hEBs that were passaged 16 times.
doi:10.1371/journal.pone.0019134.g002
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passaged after dissociation at various ratios (1:2, 1:4, and 1:6) on
the indicated days (Fig. 1Aiii). The third method for hEB
passaging was done by draining away the medium to fasten the
EBs to the dish, then the EBs were cut by a McIlwain tissue
chopper or sterile razor blade. Fully grown hEBs were sliced at a
ratio of 1:4 for subculturing and for further studies unless indicated
otherwise. The culture medium was refreshed every 2 days.
hEB growth analysis
The average diameter of the hEB populations was calculated by
measuring the large and small diagonals of ten representative hEBs
in each experimental group. To count the total number of cells
within each EB, the hEBs were dissociated into single-cell
suspensions with 0.1% trypsin-EDTA for 3 min. Live cell numbers
were determined by trypan blue (Invitrogen) exclusion. For the cell
counts, three to ten hEBs were counted in each experimental group.
Spontaneous in vitro differentiation of hEBs
After five days of growth in suspension, the cell aggregates were
seeded onto gelatin-coated plates and cultured in hEB medium for
an additional 10 days. The medium was changed every two days.
In vitro differentiation of hEBs into specific lineages
To derive neural stem spheres (NSSs), the hEBs were cultured in
NSS culture medium (DMEM/F12 supplemented with 16N2/B27
(Invitrogen), 20 ng/ml epidermal growth factor (Invitrogen), 20 ng/
ml bFGF, 10 ng/ml leukemia inhibitory factor (Sigma) and 100 U/
ml penicillin-streptomycin). The NSSs were sub-cultured every week
using a McIlwain tissue chopper (Mickle Engineering, Gomshall,
Surrey, UK), and the medium was refreshed every 2 days. For
terminal differentiation into neurons, oligodendrocytes, astrocytes,
the NSSs were allowed to attach to Matrigel-coated coverslips and
maintained in the same NSS medium without growth factors for 3–4
weeks. For osteoblast differentiation, the hEBs were plated in
Matrigel-coated dishes and cultured in medium containing osteo-
genic supplements and 0.1 mM L-ascorbic acid (Sigma), 10 mM b-
glycerophosphate (Sigma), and 0.1 mM dexamethasone (Sigma) for
3–4 weeks. For cardiomyocyte differentiation, the hEBs were plated
in gelatin-coated cell culture dishes in differentiation medium
consisting of Knockout DMEM (Invitrogen), 20% FBS (Invitrogen),
1% non-essential amino acids, 1 mM L-glutamine, 0.1 mM b-
mercaptoethanol, and 1% penicillin/streptomycin for 3 weeks. For
endothelial cell differentiation, the following protocol was used: hEBs
were maintained in hEB medium supplemented with 20 ng/ml
BMP4(R&DSystems)(removedonday7);onday1,themediumwas
supplemented with 10 ng/ml activin A (Peprotech) (removed on day
4); on day 2, the medium was supplemented with 8 ng/ml bFGF
(R&D Systems) (for the duration of the culture); on day 4, the EBs
were transferred to adherent conditions in Matrigel-coated plates,
and the medium was supplemented with 25 ng/ml VEGF-A
(Peprotech) (for the duration of the culture); finally, on day 7,
10 mM SB431542 (Sigma) was added to the culture followed by an
incubation for 7 days.
Figure 3. Proliferation rates for hEBs. The 7 d-hEBs (1 w) were cultured without passaging for 5 weeks (5 w) and with passaging (p1 and p5). (A)
Representative images (left panel) and quantification of BrdU
+ cells (right panel). The relative number of BrdU
+ cells per field of vision was quantified,
and the results are presented as the percentage of the total number of cells counted. The data represent the mean 6 SEM (n=3). (B) Western blot
analysis of phosphorylated Akt proteins. w: week, p: passage.
doi:10.1371/journal.pone.0019134.g003
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Total RNA was isolated from the cells using the RNeasy Mini
Kit (Qiagen, Valencia, CA) and reverse-transcribed using the
SuperScript First-strand Synthesis System Kit (Invitrogen) accord-
ing to the manufacturers’ protocols. Semi-quantitative RT-PCR
and real-time PCR were performed using methods and primers
described in Text S1 and Table S1.
Immunocytochemistry
Cells that had been cultured on gelatin-coated 4-well Lab-Tek
chamber slides (Nunc, Naperville, IL) were fixed with 4%
paraformaldehyde, permeabilized in PBS/0.2% BSA/0.1% Triton
X-100 and blocked with 4% normal donkey serum (Molecular
Probes, Eugene, OR, USA) in PBS/0.2% BSA for 1 h at RT. After
blocking, the cells were incubated with the respective primary
antibodies diluted in PBS/0.2% BSA. After washing, the cells were
incubated with FITC- or Alexa 594-conjugated secondary antibod-
ies (Invitrogen) in PBS/0.2% BSA for 1 hr at RT. Nuclei were then
counterstained with 10 mg/ml DAPI (49,6-diamidino-2-phenylin-
dole). The chamber slides were analyzed using an Olympus
microscope or an Axiovert 200 M microscope (Carl Zeiss,
Gottingen, Germany). The antibodies used are listed in Table S2.
Results and Discussion
In general, after the formation of hEBs in suspension for 2–4
days, they can be further maintained in culture for approximately
Figure 4. Cell-cycle and apoptosis analysis of hEBs. (A) Cell-cycle analysis of hEBs using propidium iodide staining. The percentages of cells in
G1, S, and G2/M are depicted in the graph representing the means 6 SEM (n=3). (B) Apoptosis analysis of hEBs using annexin-V/PI staining. hEBs
were formed either with or without enzymatic treatment (collagenase IV) and maintained either with (p1, p2, p3, p4, and p5) or without passaging
(1 w, 2 w, 3 w, 4 w, and 5 w). Values shown in the graphs represent the mean 6 SEM (n=3).
doi:10.1371/journal.pone.0019134.g004
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passaging (Fig. 1Ai and ii). During cultivation, an increase in the cell
numberand size wasobserved inhEBcell populations upto about 2
weeks (Fig. 1Bi and ii, Fig. 2A and B, and Table S3). However, after
a prolonged incubation (over 2 weeks), a decrease in healthy normal
hEBs, an increase in hEB heterogeneity and cell debris, and
vascularized cystic hEBs were all observed, despite the initial
formation of uniform hEBs (Fig. 1Bi and ii and Fig. 2B). These
morphological characteristics are suggestive of both decreased cell
growth and proliferation and increased apoptosis in long-term-
cultured hEB populations. Under these conditions, the ability to
increase hEB production requires scaling-up of the hESC/hiPSC
culture process, which involves variegated, time-consuming, and
expensive methods and large quantities of hESC clumps.
Therefore, we attempted to develop a simple, efficient method
for scaling-up hEB production through hEB passaging as
illustrated in Figure 1Aiii. The hiPSCs used in the present study
were generated from human fibroblasts through retroviral
transduction of the four transcription factors Oct4, Sox2, Klf4,
and c-Myc (Fig. S1). First, we acquired regular-sized 7-day-old
hEBs (mean diameter of 290 mm, 7.6610
360.61 cells per hEB)
from hESC/hiPSC clumps (6006600 nm, 1.7610
360.187 cells
per clump) (Tables S3 and S4). These regular-sized clumps were
prepared from monolayer-cultured hESCs/hiPSCs using auto-
mated tissue choppers (Fig. 1C). Next, 7-day-old hEBs were
passaged by cutting them using sterile razor blades into 2, 4, or 6
pieces which were almost the same shape and size, and then they
were maintained in a suspension culture (Fig. 1Aiii and D).
Passaged hEBs demonstrated successful re-growth back to volumes
and cell numbers comparable to those observed for 7-day-old
hEBs. These results were observed after 6 (2 pieces, 1:2 ratio), 8 (4
pieces, 1:4 ratio), and 14 (6 pieces, 1:6 ratio) days of incubation, as
confirmed by a morphological observation (Fig. 1B and D),
diameter measurements (Fig. 2D and F) and cell counts (Fig. 2C
and E). Size-controlled hEBs (6006600 mm) derived from hESCs
and hiPSCs were periodically passaged by mechanical splitting
(1:4 ratio) and successfully maintained for more than 15 passages
(Fig. 1Biii, Fig. 2F and G).
Passaged hEBs (passage 1, 2, 5, or 15) showed no marked
differences in cell growth (Fig. 2C, D, and F) or the proliferation
rate (Fig. 3A) when compared to freshly formed 7-day-old hEBs
(7 d-hEBs). In contrast, hEBs maintained under un-passaged
conditions for 5 weeks (5 w-hEBs; 56.763.2%) displayed a marked
decrease in cell proliferation as compared to 7 d-hEBs
(83.264.4%) and passaged hEBs (hEBs at passage 1;
80.762.2%, hEBs at passage 5; 85.165.2%), as determined by
BrDU
+ cell counts (Fig. 3A). However, the decrease in hEB cell
proliferation was not associated with the activity of the
multifunctional serine/threonine kinase Akt, which plays a critical
role in signal transduction pathways involved in cell proliferation
(Fig. 3B) [18]. These results suggest that un-passaged hEBs were
less proliferative compared to passaged hEB cell populations.
Next, we characterized the effect of hEB passaging on cell cycle
and apoptosis. Flow cytometry-based cell-cycle analysis showed that
a large number of hEB cell populations contained a relatively high
percentage of G0/G1 phase cells (63.23%60.59) and a low
percentage of S (21.1%61.92) and G2/M phase cells
(15.68%62.33) in 7 d-hEBs (Fig. 4A). Passaged hEBs displayed
no marked differences in the cell-cycle distribution relative to 7 d-
hEBs, however, 5 w-hEBs demonstrated a reduced number of cells
in S phase (12.64%; p,0.05) and an increased number of cells in
G2/M phase (26.78%; p,0.01) (Fig. 4A). In parallel, passaged
hEBs displayed no apparent signs of apoptosis, as indicated by the
lack of a significant induction of annexin-V-binding populations
(Fig. 4B). However, an approximately 6-fold increase in annexin-V-
positive apoptotic cells was observed in hEBs that were maintained
under un-passaged conditions for 4 weeks (12.30%; p,0.01) as
compared to 7 d-hEBs (2.1661.12%). By contrast, passaged hEBs
(passage 5; 0.4160.04%) demonstrated fewer apoptotic cells
(Fig. 4B). As expected, an increase in apoptosis was observed in
hEBs that were generatedusingcollagenase IV treatment compared
to those that were not treated with the enzyme, and annexin-V-
positive cells were evident within 1–2 weeks of the incubation
(Fig. 4B). Reports have shown that the levels of mitochondrial
biosynthesis, DNA damage, and oxidative stress are up-regulated
while telomerase activity is down-regulated during hESC differen-
tiation [19], and hiPSCs possess stress defense mechanisms that are
similar to those of hESCs [20]. As expected, the carbonyl signal was
significantly increased by approximately 1.76-fold in 5 w-hEBs
cultured without passaging compared to 7 d-hEBs, whereas in
passaged hEBs (passages 1 and 5), this signal remained unchanged
(Fig. 5). These data suggest that increased oxidative stress may
contribute to the increased apoptosis observed in long-term-
cultured hEBs under un-passaged conditions.
Figure 5. Protein oxidation assay in hEBs. Left: Representative image for the OxyBlot assay, which detects the level of proteins with oxidative
modifications. Right: For protein quantification, the blots were scanned, and the bands were quantified by densitometry. The data represent the
mean 6 SEM (n=3).
doi:10.1371/journal.pone.0019134.g005
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19134Figure 6. In vitro differentiation of hEBs. (A) Immunocytochemical analysis of the spontaneous differentiation of passaged hEBs. Lineage-specific
markers of three germ layers, ectoderm (Tuj1 and nestin), mesoderm [desmin and a-smooth muscle actin (a-SMA)], and endoderm [Sox17 and a-
fetoprotein (AFP)] were detected in hEBs derived from hESCs (H9 and H1) and hiPSCs cultured with or without passaging. Nuclei were stained with
DAPI. H9 hEB; hEBs derived from H9 hESCs, H1 hEB; hEBs derived from H1 hESCs, iPS-hEBs; hEBs derived from hiPSCs. (B) Quantitative real-time PCR
analysis of spontaneous differentiation using markers of pluripotency (Oct4 and Nanog) and the three germ layers [ectoderm (NCAM, PAX6, and
SOX1), mesoderm (MSX1, IGF2, and COL1A1), and endoderm (GATA6, HGF, and amylase)] in H9 hEBs cultured with or without passaging. For hEB
formation, hESCs were dislodged either in the presence or absence of enzymatic treatment (collagenase IV). Each group was compared with control
hESCs. Statistical significance was calculated using Student’s t-test: *P,0.05; **P,0.01 (C) In vitro differentiation of passaged H9 EBs into specific
lineages, including neural cells (ectoderm), osteoblasts (mesoderm), cardiomyocytes (mesoderm) and endothelial cells (endoderm). Ectoderm: Neural
stem spheres derived from hEBs (passage 17) were allowed to attach to culture dishes and further differentiated into mature neural phenotypes.
Neural cells were detected by positive immunostaining for neuronal markers: MAP2 (neurons), O4 (oligodendrocytes) and GFAP (astrocytes).
Mesoderm: Osteoblasts differentiated from hEBs (passage p15) were characterized by positive staining for mineralized bone nodule-specific alizarin
red S and osteocalcin proteins. Cardiomyocytes differentiated from hEBs (passage p15) were characterized by positive immunostaining for cTnT,
MHC, and Nkx2.5. Endoderm: Endothelial cells differentiated from hEBs (passage p15) were characterized by positive immunostaining for PECAM and
VE-cadherin (VE-cad). Cell nuclei were visualized with DAPI. (D) Heat map analysis of pluripotency and lineage-specific marker genes. A global gene
expression analysis in H9 hESCs (H9), OSKM-hiPSCs (iPS), H9 hEBs, and iPS-hEB was conducted using Agilent Human Genome 44k Arrays. Pluripotency
and lineage-specific genes were selected, and their expression levels in hEBs and hESCs/hiPSCs were analyzed. Mean gene expression ratios of hEBs
relative to hESCs or hiPSCs were calculated and the ratios are color-coded, as indicated by the color index bar. Red: up-regulated genes as compared
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we examined the differentiation capacity of passaged EBs derived
from hESCs and hiPSCs in vitro. We observed that hEBs
maintained both with and without subculture were fully
differentiated, as evidenced by the down-regulation of pluripoten-
cy markers and up-regulation of mRNAs (Fig. 6B and Fig. S2A
and B) and/or proteins (Fig. 6A) specific for ectoderm, mesoderm,
and endoderm markers. Statistical analysis of multiple markers
(NCAM, PAX6, IGF2, COL1A1, GATA6, HGF, and Amylase)
for three-germ layers showed that linage-specific maker genes
displayed relatively constant expression levels among hEBs of
different passages, whereas some markers such as SOX1, MSX1,
and HGF displayed different expression levels (Fig. 6B). Develop-
mental potential of long-term-cultured hEBs ($15 passages) was
further confirmed by their successful differentiation into specific
lineages, such as neural cells (neurons, oligodendrocytes, and
astrocytes), osteoblasts, cardiomyocytes, and endothelial cells by
confirming the expression of markers specific for each lineage at
the mRNA (Fig. S2C) and protein level (Fig. 6C). Although some
slight differences were observed among the hEB populations, a
microarray analysis using Agilent’s Whole Genome Human 44K
also confirmed the common up-regulation of selected lineage
marker genes for ectoderm, mesoderm, and endoderm and the
concomitant down-regulation of pluripotency marker genes in
hEBs maintained both with and without subculture (Fig. 6D and
Table S3). In addition, the long-term-maintained hEBs with
continuous passaging retained normal karyotypes (Fig. S3). These
results indicate that the regenerative abilities are maintained in
EBs during propagation by serial passage. However, more detailed
further studies are needed to determine whether trivial differences
on lineage-specific gene expression observed in EBs of different
passages can influence (thereby limits) the differentiation potential
of EBs.
Overall, the long-term-maintained hEBs (over 2 weeks) without
subculture exhibited a decrease in cell proliferation, G2/M arrest,
an increased level of apoptosis, and free radical protein damage.
These biological and physical obstacles raised during long-term
culture of hEBs can be overcome with our new culture method
that utilizes the passaging of hEBs. hEBs maintained for long-term
($15 passages) are proliferative, show low rates of apoptosis, and
possess a multilineage differentiation potential similar to that
observed in freshly formed hEB. For mass production, only one
culture of hESCs/iPSCs for hEB formation was required, and the
hEB cell populations could be continuously expanded for more
than 20 passages. We were able to scale-up hEB production by
about 19 (1:2 ratio)–369 (1:6 ratio) folds (mean values) over the
conventional method after five weeks of culture (Table S5). We
anticipate that the subculturing method of hEBs will therefore be
of great benefit for the maintenance of the hEB’s regenerative
potential and the development of hEB-derived products for
applications in therapeutics and drug discovery.
Supporting Information
Figure S1 Characterization of hiPSCs derived from
human fibroblasts. (A) Morphology of a representative iPSC
colony with high levels of alkaline phosphatase (ALP) and positive
immunostaining for two pluripotency markers: OCT4 and Nanog.
Cell nuclei were visualized with DAPI. (B) Semi-quantitative RT-
PCR analysis of pluripotency gene expression in human foreskin
fibroblasts (hFFs), H9 hESs, and hiPSs. GAPDH was used as a
loading control. (C) PCR analysis of retroviral integration in
genomic DNA from hiPSs. (D) Bisulfite sequencing to measure the
DNA methylation status in the promoter region of the OCT4 and
NANOG genes in H9 hESs, hiPSs, and hFFs. The promoter
regions of OCT4 and NANOG were amplified by PCR using
using specific primer sets, and the methylation status was analyzed.
Each horizontal row of circles represents an individual sequencing
result from one amplicon. Open and black circles indicate
demethylated and methylated CpGs, respectively. The proportion
of methylated CpGs is indicated.
(TIF)
Figure S2 Semi-quantitative RT-PCR analysis of the in
vitro differentiation assays. hEBs were formed either with (1)
or without enzymatic treatment (collagenase IV) (2) and cultured
with (p5, p15, and p17) or without passaging (5 w) for various
periods as indicated. (1) 5 w: hEBs formed with enzymatic
treatment and cultured for 5 weeks without passaging, (2) 5 w:
hEBs formed without enzymatic treatment and cultured for 5
weeks without passaging. (A and B) The spontaneous differenti-
ation potential of H9 hEBs (A) and iPS-hEBs (B) and the directed
differentiation potential of H9 hEBs (passage 17) into neural cells,
osteoblasts, cardiomyocytes and endothelial cells (C), were
determined based on the detection of two pluripotency markers
(Oct4 and Nanog) and/or lineage specific markers of the three
germ layers using the validated primer sets shown in Table S1.
(TIF)
Figure S3 Karyotype analysis of long-term-maintained
hEBs with passage. After the H9 hEBs and iPS-hEBs had been
serially passaged at a ratio of 1:4 as indicated, the karyotype was
analyzed using the G-banding method.
(TIF)
Table S1 List of primers used in this study.
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Table S2 List of antibodies used in this study.
(DOCX)
Table S3 Expression difference for pluripotency and lineage
marker genes in hEB samples comparing to human pluripotenct
stem cells.
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conditions.
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